Scarica l'app Stockscreener
1.38
5.34%
0.07
Pre-mercato:
1.38
Precedente Chiudi:
$1.31
Aprire:
$1.32
Volume 24 ore:
203.01K
Relative Volume:
0.09
Capitalizzazione di mercato:
$19.02M
Reddito:
-
Utile/perdita netta:
$-8.83M
Rapporto P/E:
-1.7455
EPS:
-0.7906
Flusso di cassa netto:
$-8.61M
1 W Prestazione:
-0.72%
1M Prestazione:
-8.61%
6M Prestazione:
+32.69%
1 anno Prestazione:
-8.61%
Intervallo 1D:
$1.32
$1.42
Intervallo di 1 settimana:
$1.28
$1.4798
Portata 52W:
$0.8588
$2.67
Cocrystal Pharma Inc Stock (COCP) Company Profile
Nome
Cocrystal Pharma Inc
Settore
Industria
Telefono
(786) 459-1831
Indirizzo
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.38 | 19.02M | 0 | -8.83M | -8.61M | -0.7906 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-07-08 | Iniziato | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Borsa (COCP) Ultime notizie
[EFFECT] Cocrystal Pharma, Inc. SEC Filing - Stock Titan
Cocrystal Showcases Norovirus Candidate CDI-988 at ICAR 2026 - TipRanks
Cocrystal Pharma (COCP) advances Fast Track CDI-988 in Phase 1b norovirus challenge study - Stock Titan
No approved norovirus drugs; Cocrystal tests oral CDI-988 - Stock Titan
COCP stock soars 75% — what is the link to Cocrystal’s norovirus treatment? - MSN
Cocrystal Pharma Incfiles to offer up to $150 million in securitiesSEC filing - marketscreener.com
Cocrystal Pharma (NASDAQ: COCP) files $150M shelf to offer stock and warrants - Stock Titan
COCP: Q4 2025 Earnings: Cocrystal Pharma Inc. posts 4.8% EPS beat with no Q4 revenueTop Analyst Buy Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Cocrystal (COCP) Stock: Why Efficiency Gains (Momentum Building) 2026-04-22RSI Oversold Stocks - Xã Vĩnh Công
Why Cocrystal Pharma Shares Are Cooling Off Monday? - MSN
Form 8-KCurrent report - ADVFN
Cocrystal Pharma (COCP) price target increased by 33.33% to 8.16 - MSN
Smart Money: Can Cocrystal Pharma Inc deliver consistent EPS growth2026 Technical Patterns & Daily Growth Stock Tips - baoquankhu1.vn
Investor Mood: Is Cocrystal Pharma Inc benefiting from innovation trendsQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
What events could move Cocrystal (COCP) Stock next | Price at $1.29, Down 9.79%Crowd Trend Signals - Newser
Tech Rally: Is Cocrystal Pharma Inc stock risky to hold nowMarket Activity Summary & Consistent Profit Trading Strategies - baoquankhu1.vn
COCP: Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Prevention - Zacks Small Cap Research
Is Cocrystal (COCP) Stock Cheap at Current Price | Price at $1.47, Down 2.00%Support Bounce - Newser
Cocrystal Pharma, Inc. (COCP) stock price, news, quote and history - Yahoo Finance UK
COCP PE Ratio & Valuation, Is COCP Overvalued - Intellectia AI
We're Keeping An Eye On Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate - Yahoo Finance
Shares +48% after hours: COCP Cocrystal Pharma NASDAQ 03 Apr earnings spotlight - meyka.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results - Sahm
Nasdaq Down 1%; US Initial Jobless Claims Fall - Sahm
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988 - Sahm
COCP Stock Analysis: Cocrystal Pharma Inc. biotech stock surges 48 percent to 1.51 level - Xã Vĩnh Công
FDA grants fast track status to Cocrystal’s norovirus drug By Investing.com - Investing.com Australia
Cocrystal Pharma stock surges on FDA Fast Track designation By Investing.com - Investing.com Canada
Cocrystal Pharma (COCP) Receives FDA Fast Track Status for Norov - GuruFocus
Cocrystal Pharma stock surges on FDA Fast Track designation - Investing.com
Cocrystal Pharma, Inc. (8CC.F) stock price, news, quote and history - Yahoo Finance UK
Cocrystal Pharma Advances in Norovirus Study as Financial Challenges Loom - StocksToTrade
Cocrystal Pharma Wins FDA Fast Track for Norovirus Drug - TipRanks
COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment? - Stocktwits
Cocrystal Pharma Advances Antiviral Trials Amid Financial Strategy Shift - timothysykes.com
FDA grants fast track status to Cocrystal’s norovirus drug - Investing.com
FDA Fast Track backs Cocrystal (Nasdaq: COCP) oral norovirus antiviral CDI-988 - Stock Titan
Cocrystal Pharma Inc Azioni (COCP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cocrystal Pharma Inc Azioni (COCP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director |
Feb 06 '26 |
Buy |
0.95 |
50,000 |
47,280 |
1,888,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 31 '25 |
Buy |
0.95 |
50,000 |
47,275 |
1,838,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 30 '25 |
Buy |
0.97 |
20,000 |
19,310 |
1,788,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 26 '25 |
Buy |
0.97 |
40,000 |
38,944 |
1,768,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 24 '25 |
Buy |
0.97 |
25,000 |
24,258 |
1,728,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 26 '25 |
Buy |
0.99 |
4,000 |
3,975 |
1,703,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 25 '25 |
Buy |
0.94 |
20,000 |
18,812 |
1,699,551 |
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):